BIOGEN INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

BIOGEN INC. reported Cash And Cash Equivalents At Carrying Value of $2.91 billion for the year ending 2019.

  • BIOGEN INC. showed an increase of +137.9% in Cash And Cash Equivalents At Carrying Value from 2018 to 2019.
  • This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 6, 2020.
  • XBRL data for this metric is available from 2006 to 2019 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2008: $466.49 million | Q3 2008: $1.01 billion | Q1 2009: $764.10 million | Q2 2009: $786.80 million | Q3 2009: $585.79 million | Q1 2010: $639.56 million | Q2 2010: $720.96 million | Q3 2010: $626.76 million | Q1 2011: $790.68 million | Q2 2011: $697.53 million | Q3 2011: $575.14 million | Q1 2012: $298.14 million | Q2 2012: $456.81 million | Q3 2012: $451.72 million | Q1 2013: $663.30 million | Q2 2013: $392.51 million | Q3 2013: $427.81 million | Q1 2014: $828.60 million | Q2 2014: $863.20 million | Q3 2014: $1.19 billion | Q1 2015: $1.48 billion | Q2 2015: $1.28 billion | Q3 2015: $4.09 billion | Q1 2016: $1.13 billion | Q2 2016: $1.36 billion | Q3 2016: $2.08 billion | Q1 2017: $924.00 million | Q2 2017: $1.17 billion | Q3 2017: $1.55 billion | Q1 2018: $4.11 billion | Q2 2018: $1.25 billion | Q3 2018: $2.39 billion | Q1 2019: $2.24 billion | Q2 2019: $1.72 billion | Q3 2019: $2.34 billion.
  • Over the full 14 years of available data (2006 to 2019), BIOGEN INC.'s Cash And Cash Equivalents At Carrying Value has grown by 340.6%.
  • Historical annual values: Fiscal year 2019: $2.91 billion | Fiscal year 2018: $1.22 billion | Fiscal year 2017: $1.57 billion | Fiscal year 2016: $2.33 billion | Fiscal year 2015: $1.31 billion | Fiscal year 2014: $1.20 billion | Fiscal year 2013: $602.60 million | Fiscal year 2012: $570.70 million | Fiscal year 2011: $514.54 million | Fiscal year 2010: $759.60 million | Fiscal year 2009: $581.89 million | Fiscal year 2008: $622.39 million | Fiscal year 2007: $659.66 million | Fiscal year 2006: $661.38 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: